Quarterly report [Sections 13 or 15(d)]

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.26.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2024 $ 852 $ 67,936,225 $ (67,321,956) $ 615,121
Balance at beginning (in shares) at Dec. 31, 2024 851,534      
Share-Based Compensation   333,598   333,598
Share-Based Compensation to settle accrued compensation   413,120   413,120
Share-Based Payments to Vendors $ 8 110,072   110,080
Share-Based Payments to Vendors (in shares) 7,938      
Issuance of shares of common stock in January Registered Direct Offering, net of $400,750 cash issuance costs $ 123 2,099,130   2,099,253
Issuance of shares of common stock in January Registered Direct Offering, net of $400,750 cash issuance costs (in shares) 123,153      
Issuance of shares of common stock and pre-funded warrants in March Registered Direct Offering, net of $208,580 cash issuance costs $ 107 889,313   889,420
Issuance of shares of common stock and pre-funded warrants in March Registered Direct Offering, net of $208,580 cash issuance costs (in shares) 107,500      
Pre-funded Warrant Exercise $ 30 (30)    
Pre-funded Warrant Exercise (in shares) 29,750      
Net Loss     (2,149,193) (2,149,193)
Balance at ending at Mar. 31, 2025 $ 1,120 71,781,428 (69,471,149) 2,311,399
Balance at ending (in shares) at Mar. 31, 2025 1,119,875      
Balance at beginning at Dec. 31, 2025 $ 2,348 80,554,738 (75,288,494) $ 5,268,592
Balance at beginning (in shares) at Dec. 31, 2025 2,348,113     2,348,113
Share-Based Compensation   258,287   $ 258,287
Share-Based Payments to Vendors $ 25 60,975   61,000
Share-Based Payments to Vendors (in shares) 24,874      
Issuance of shares of common stock related to equity line of credit purchase agreement, net of $144,991 cash issuance costs $ 1,016 3,105,230   3,106,246
Issuance of shares of common stock related to equity line of credit purchase agreement, net of $144,991 cash issuance costs (in shares) 1,016,119      
Net Loss     (1,680,982) (1,680,982)
Balance at ending at Mar. 31, 2026 $ 3,389 $ 83,979,230 $ (76,969,476) $ 7,013,143
Balance at ending (in shares) at Mar. 31, 2026 3,389,106     3,389,106